Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-09-08Clinical Trial Update: Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 2]
Phase 2 clinical trial evaluating HL-1186 for diabetic peripheral neuropathy-related pain is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Implementation of Telemedicine for Patient With Lower Extremity Wounds [NA]
Clinical trial update indicates completion of a study evaluating telemedicine for managing lower extremity wounds in patients with periphera…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Buerger Exercises With Whole Body Vibration in Diabetic Peripheral Neuropathy [NA]
A completed clinical trial evaluating Buerger exercises combined with whole-body vibration for diabetic peripheral neuropathy, including ass…
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for pregabalin, authorizing the marketing of a generic pregabalin product.
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved a supplemental application for pregabalin from ScieGen Pharmaceuticals, Inc., confirming approval of the generic product under …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Effects of Insole Vibration With Proprioceptive Training in Patients With Diabetic Peripheral Neuropathy [NA]
A completed clinical trial evaluating insole vibration with proprioceptive training for diabetic peripheral neuropathy. Sponsor: Riphah Inte…
-
FDA approval · 2025-08-18FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Pregabalin submitted by Rising Pharma Holdings, Inc. under the approved ANDA.
-
FDA approval · 2025-08-15FDA Approved: PREGABALIN — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for pregabalin from Indoco Remedies Limited, resulting in approval of a generic pregabalin product.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain [NA]
A completed clinical trial evaluated the Erchonia EVRL device for temporary relief of foot pain in diabetic peripheral neuropathy, including…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP [Phase 1]
An ongoing Phase 1 MAD study assessing the safety, tolerability, pharmacokinetics, and efficacy of YJ001 spray in patients with diabetic per…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 clinical trial evaluating melatonin for diabetic peripheral neuropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Effect of an Exercise Program on Motor Dysfunctions Caused by Diabetic Peripheral Neuropathy [NA]
This clinical trial update describes a study evaluating whether an exercise program can improve motor dysfunction in diabetic peripheral neu…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading
This clinical trial aims to evaluate the clinical effect of a femoral nerve block using a low concentration of ropivacaine in patients with …
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Multi-Sensory Training for Balance, EMG, Sensory Deficits in DPN [NA]
A completed clinical trial evaluating multi-sensory training for balance, EMG, and sensory deficits in diabetic peripheral neuropathy.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy [NA]
This update describes an ongoing Sakarya University clinical trial investigating whether hand and foot exercises combined with cold applicat…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Walking Function in Diabetic Peripheral Neuropathy [NA]
A clinical trial update shows a study recruiting to evaluate walking function in individuals with diabetic peripheral neuropathy. The sponso…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China
A completed clinical trial update reports real-world pharmacological treatment patterns for neuropathic pain in China, including diabetic pe…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 clinical study evaluating the efficacy of Levagen+ for diabetic peripheral neuropathy; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy [NA]
Clinical trial update on using spinal cord stimulation for diabetic peripheral neuropathy; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Tai Chi vs. Modified-Otago Exercises for Pain, Balance, and Motor Function in Diabetic Peripheral Neuropathy [NA]
A clinical trial compares Tai Chi to Modified-Otago exercises to improve pain, balance, and motor function in individuals with diabetic peri…
-
FDA approval · 2025-07-21FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for pregabalin. The approval enables the marketing of a generic pregabalin pr…
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Pregabalin from Torrent Pharmaceuticals Limited, enabling the generic drug to be marketed.
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for pregabalin filed by Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]
A Phase 2 clinical trial evaluating LY3556050 in adults with diabetic peripheral neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) [Phase 2]
Phase 2 trial evaluating VX-548 for painful diabetic peripheral neuropathy has completed and results have been posted.